KR100648761B1 - 저산소증-유도성 인자 1α HIF-1α 변이체 및HIF-1α 조절제의 동정 방법 - Google Patents

저산소증-유도성 인자 1α HIF-1α 변이체 및HIF-1α 조절제의 동정 방법 Download PDF

Info

Publication number
KR100648761B1
KR100648761B1 KR1020017005928A KR20017005928A KR100648761B1 KR 100648761 B1 KR100648761 B1 KR 100648761B1 KR 1020017005928 A KR1020017005928 A KR 1020017005928A KR 20017005928 A KR20017005928 A KR 20017005928A KR 100648761 B1 KR100648761 B1 KR 100648761B1
Authority
KR
South Korea
Prior art keywords
hif
leu
ser
thr
glu
Prior art date
Application number
KR1020017005928A
Other languages
English (en)
Korean (ko)
Other versions
KR20010080411A (ko
Inventor
베르켄스탐안데르스
포엘린거로렌츠
Original Assignee
앤지오제네틱스 스웨덴 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 앤지오제네틱스 스웨덴 에이비 filed Critical 앤지오제네틱스 스웨덴 에이비
Publication of KR20010080411A publication Critical patent/KR20010080411A/ko
Application granted granted Critical
Publication of KR100648761B1 publication Critical patent/KR100648761B1/ko

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Amplifiers (AREA)
  • Semiconductor Lasers (AREA)
  • Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
KR1020017005928A 1998-11-13 1999-11-11 저산소증-유도성 인자 1α HIF-1α 변이체 및HIF-1α 조절제의 동정 방법 KR100648761B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803891-2 1998-11-13
SE9803891A SE9803891D0 (sv) 1998-11-13 1998-11-13 Protein Variants

Publications (2)

Publication Number Publication Date
KR20010080411A KR20010080411A (ko) 2001-08-22
KR100648761B1 true KR100648761B1 (ko) 2006-11-23

Family

ID=20413284

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017005928A KR100648761B1 (ko) 1998-11-13 1999-11-11 저산소증-유도성 인자 1α HIF-1α 변이체 및HIF-1α 조절제의 동정 방법

Country Status (15)

Country Link
EP (1) EP1141005B1 (zh)
JP (1) JP2002530063A (zh)
KR (1) KR100648761B1 (zh)
CN (1) CN1330666C (zh)
AT (1) ATE374210T1 (zh)
AU (1) AU761594B2 (zh)
BR (1) BR9915263A (zh)
CA (1) CA2350830A1 (zh)
DE (1) DE69937199D1 (zh)
HK (1) HK1043372B (zh)
NZ (1) NZ511450A (zh)
SE (1) SE9803891D0 (zh)
TR (1) TR200101345T2 (zh)
WO (1) WO2000029437A1 (zh)
ZA (1) ZA200103669B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9911047D0 (en) 1999-05-12 1999-07-14 Isis Innovation Assay method and means
ATE383877T1 (de) * 1999-06-04 2008-02-15 Dana Farber Cancer Inst Inc Identifikation von stoffen, die transkriptionelle antworten auf hypoxia modifizieren
WO2001092578A2 (en) * 2000-05-26 2001-12-06 Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of genes regulated by retinoids
CA2418386A1 (en) * 2000-08-07 2002-02-14 Angiogenetics Sweden Ab Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
EP1842856A3 (en) * 2001-05-23 2007-12-12 Angiogene Inc. Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
WO2002094862A2 (en) 2001-05-23 2002-11-28 Angiogene Inc. Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
WO2003064587A2 (en) * 2002-01-11 2003-08-07 Angio Genetics Sweden Ab Hif-1 alpha proteins mutated in the c-terminal transactivation domain
CN100366747C (zh) * 2005-03-08 2008-02-06 上海第二医科大学附属仁济医院 低氧诱导因子小干扰rna质粒
CN100418574C (zh) * 2005-10-26 2008-09-17 王成球 一类封闭人类HIF-1α基因和调控网络中下游相关基因的染色质肽
CN102127161B (zh) * 2010-12-16 2013-03-27 何明忠 抗肿瘤多肽及其用途
CN106366173A (zh) * 2015-07-24 2017-02-01 北京京爱康科技有限公司 一种通过结合低氧反应元件控制缺氧反应基因表达的染色质肽

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1

Also Published As

Publication number Publication date
SE9803891D0 (sv) 1998-11-13
ATE374210T1 (de) 2007-10-15
TR200101345T2 (tr) 2001-10-22
AU761594B2 (en) 2003-06-05
JP2002530063A (ja) 2002-09-17
CA2350830A1 (en) 2000-05-25
EP1141005B1 (en) 2007-09-26
ZA200103669B (en) 2002-05-07
HK1043372A1 (en) 2002-09-13
WO2000029437A1 (en) 2000-05-25
EP1141005A1 (en) 2001-10-10
AU1593100A (en) 2000-06-05
DE69937199D1 (de) 2007-11-08
CN1330663A (zh) 2002-01-09
CN1330666C (zh) 2007-08-08
NZ511450A (en) 2003-08-29
KR20010080411A (ko) 2001-08-22
HK1043372B (zh) 2008-05-09
BR9915263A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
Schweitzer et al. Secreted Spitz triggers the DER signaling pathway and is a limiting component in embryonic ventral ectoderm determination.
KR100648761B1 (ko) 저산소증-유도성 인자 1α HIF-1α 변이체 및HIF-1α 조절제의 동정 방법
CA2375450C (en) Screening methods for altering circadian rhythm proteins
Maj et al. Novel insights into the distribution and functional aspects of the calcium binding protein secretagogin from studies on rat brain and primary neuronal cell culture
US7303885B1 (en) Screening method for candidate drugs
WO2000023091A2 (en) Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases
US6436654B1 (en) Methods for identifying compounds that modulate HIF-1α
US20030228607A1 (en) Screening method and modulators having an improved therapeutic profile
JP2004536552A (ja) フォン・ヒッペル・リンドウ腫瘍抑制タンパク質による低酸素誘導因子−1の条件付き調節のメカニズム
US20060199781A1 (en) Assays based on BTF3 activity
JP2011135885A (ja) 蛍光マーカータンパク質による細胞における分子事象の証明方法
US20070231835A1 (en) Proteomic Screening for Redox State Dependent Protein-Protein Interactions
Sébillon et al. COOH-terminal truncated human cardiac MyBP-C alters myosin filament organization
US7056684B2 (en) Protein-protein interactions of p66ShcA
US20060099600A1 (en) Novel acetylcholine transporter
US20050181360A1 (en) Assay for cell cycle modulators based on the modulation of cyclin d1 degradation in response to ionising radiation
US20050064384A1 (en) Recruitment of mst1 or mst2 protein kinase to induce apoptosis in eukaryotic cells
MXPA01004787A (en) HYPOXIA-INDUCIBLE FACTOR 1&agr;HIF-1&agr;VARIANTS AND METHODS FOR IDENTIFYING HIF-1&agr;MODULATORS
WO2001081587A1 (en) Acetyltransferase and uses thereof
Hergovich Studying the localization and regulation of the von Hippel-Lindau tumour suppressor protein
EP1160320A1 (en) Use of hTAFII80 and isoforms thereof for inducing apoptosis
WO2005075508A2 (en) Hyperactive stat molecules and their use in assays employing gene activation

Legal Events

Date Code Title Description
N231 Notification of change of applicant
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee